Literature DB >> 2457277

Monoclonal antibody analysis of bovine herpesvirus-1 glycoprotein antigenic areas relevant to natural infection.

R L Marshall1, B A Israel, G J Letchworth.   

Abstract

Neutralizing antigenic areas on the glycoproteins of bovine herpesvirus-1 (BHV-1) were identified by reciprocal competition radioimmunoassays using monoclonal antibodies. Three interrelated and two independent antigenic areas were identified on the 77-kDa (K) gIV envelope glycoprotein. Antigenic analysis of this protein has not been previously described. Four interrelated and one independent antigenic areas were found on the 97K gIII envelope glycoprotein. A third group of monoclonal antibodies reacting in Western blot with the 74K subunit of gI, a 130K disulfide-linked 74K/55K heterodimer, revealed four interrelated antigenic areas. All of the antigenic areas on all three glycoproteins were reactive with neutralizing monoclonal antibodies and all were targets for antibody-complement lysis. However, antibodies against gIV were the most efficient at neutralizing the virus and rendering infected cells susceptible to antibody-complement lysis. Convalescent sera from experimentally infected calves were used in a competitive radioimmunoassay to confirm that each antigenic area on the gI, gIII, or gIV glycoproteins was a target for bovine antibodies during primary infection with BHV-1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457277     DOI: 10.1016/0042-6822(88)90578-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Molecular and in vitro characterization of field isolates of bovine herpesvirus-1.

Authors:  Julian Ruiz-Saenz; Jairo Jaime; Gloria Ramirez; Victor Vera
Journal:  Virol Sin       Date:  2012-01-22       Impact factor: 4.327

2.  Characterization of an antigenic site on glycoprotein 13 (gC) of equid herpesvirus type-1.

Authors:  R Sinclair; B J Moult; J A Mumford
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Use of epitope mapping to identify a PCR template for protein amplification and detection by enzyme-linked immunosorbent assay of bovine herpesvirus type 1 glycoprotein D.

Authors:  Tomy Joseph; Japhet Lyaku; Robert A Fredrickson; Arnost Cepica; Frederick S B Kibenge
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.

Authors:  U Utz; W Britt; L Vugler; M Mach
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Characterization of the glycoprotein B gene from ruminant alphaherpesviruses.

Authors:  Carlos Ros; Sándor Belák
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

6.  Bovine cells expressing bovine herpesvirus 1 (BHV-1) glycoprotein IV resist infection by BHV-1, herpes simplex virus, and pseudorabies virus.

Authors:  C C Chase; K Carter-Allen; C Lohff; G J Letchworth
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Constitutively expressing cell lines that secrete a truncated bovine herpes virus-1 glycoprotein (gpI) stimulate T-lymphocyte responsiveness.

Authors:  T P Leary; Y Gao; G A Splitter
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

8.  Rise and survival of bovine herpesvirus 1 recombinants after primary infection and reactivation from latency.

Authors:  Frédéric Schynts; François Meurens; Bruno Detry; Alain Vanderplasschen; Etienne Thiry
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Identification of 108K, 93K, and 42K glycoproteins of bovine herpesvirus-1 by monoclonal antibodies.

Authors:  E Baranowski; J Dubuisson; P P Pastoret; E Thiry
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.

Authors:  Andrea Maria Blanc; Mabel Beatriz Berois; Lorena Magalí Tomé; Alberto L Epstein; Juan Ramón Arbiza
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.